Evidence map›Paper›PMID 40569205›Full record

ArticleChemSusChem2025

Beyond Simple Grinding: Methylammonium Chloride Promotes Sustainable, Cylinder-Free Mechanochemical Synthesis of Deferiprone.

Francesco Basoccu, Sara Piermarini, Tommaso Angelini, Massimiliano Mari, Edoardo Mariani, Alessandro Falchi, Andrea Porcheddu

Abstract read
In one paragraph

Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Francesco BasoccuDipartimento di Scienze Chimiche e Geologiche, Università degli Studi di Cagliari, Cittadella Universitaria Monserrato, S.P. Monserrato-Sestu Km 0,700, 09042, Monserrato, CA, Italy.ORCID 0000-0002-5480-1044
Sara PiermariniCentro Ricerche-Chiesi Farmaceutici S.p.A, Largo Belolli 11/a, 43126, Parma, PR, Italy.
Tommaso AngeliniCentro Ricerche-Chiesi Farmaceutici S.p.A, Largo Belolli 11/a, 43126, Parma, PR, Italy.
Massimiliano MariCentro Ricerche-Chiesi Farmaceutici S.p.A, Largo Belolli 11/a, 43126, Parma, PR, Italy.
Edoardo MarianiCentro Ricerche-Chiesi Farmaceutici S.p.A, Largo Belolli 11/a, 43126, Parma, PR, Italy.
Alessandro FalchiCentro Ricerche-Chiesi Farmaceutici S.p.A, Largo Belolli 11/a, 43126, Parma, PR, Italy.
Andrea PorchedduDipartimento di Scienze Chimiche e Geologiche, Università degli Studi di Cagliari, Cittadella Universitaria Monserrato, S.P. Monserrato-Sestu Km 0,700, 09042, Monserrato, CA, Italy.ORCID 0000-0001-7367-1102

Funding

Fondazione di Sardegna F73C23001600007MUR CUP J53D23014680001MUR CUP no. F53C22000770007MUR Project code PE0000021
6 · The paper itself

Abstract

Thalassemias are a group of inherited hemoglobinopathies that disrupt normal hemoglobin synthesis. Managing these conditions often involves regular blood transfusions and iron chelation therapy to mitigate iron overload. Among the available chelators, deferoxamine, deferasirox, and deferiprone, the latter stands out notably for its use when other drugs are ineffective or intolerable for patients. Although the synthesis of deferiprone is well-documented, traditional methods typically involve lengthy reaction times and environmentally harmful conditions. This study investigates mechanochemistry as a more sustainable, efficient, and eco-friendly alternative. Deferiprone is successfully synthesized and the production process is optimized by employing solid-state techniques, thereby reducing reaction time, energy consumption, and environmental impact. These findings pave the way for cleaner and more sustainable manufacturing pathways for this critical agent in thalassemia management.

Indexed as

DeferiproneMechanical PhenomenaQuaternary Ammonium CompoundsChemistry Techniques, SyntheticGreen Chemistry TechnologyDeferiproneQuaternary Ammonium CompoundsAPIsdeferipronegreen chemistrymechanochemistrythalassemia

Identifiers

PMID40569205
PMCPMC12330328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.